Canton’s Roaring Brook Nature Center is preparing in late summer to start a $725,000 renovation that also will expand the facility’s square footage by more than a third.
Celebrity chef-entrepreneur Rob Maffucci is preparing to debut his new downtown Hartford restaurant concept just blocks from his former Vito's By The Park eatery.
Connecticut residents who remember the enactment of the state income tax in 1991 can only laugh ruefully as state government's revenue collapses again, this time largely on account of falling receipts from the income tax. Twenty-six years ago the tax's advocates declared that the income tax would stabilize revenue and be much more reliable than other taxes. But now receipts from other taxes are holding up far better than those from the income tax.
Salespeople are always alert for “buying signals,” those indications that the customer is ready to say “yes.” When this happens, the savvy salesperson knows it's time to stop talking and ask for the order.
Q&A talks with Michael Cantor, co-managing partner of Hartford-based Cantor Colburn LLP, one of the largest intellectual property law firms in the country.
Capping a week in which the state's projected two-year deficit jumped from $3.6 billion to around $5 billion — raising concerns that the legislature may raise income taxes — a senior executive at Farmington manufacturer Trumpf Inc. delivered what could only be seen as a strong message to Connecticut lawmakers.
The ovarian cancer treatment research Dr. Pramod Srivastava is doing at UConn Health represents the kind of collaboration and convergence of scientists that the Connecticut Institute for Clinical and Translational Science at UConn (CICATS) supports and which it believes can advance new ways of thinking and discoveries.
When Farmington-based Diameter Health's software was combing through a health system's electronic medical records recently, it found that the hospital incorrectly labeled penicillin as pain medicine.
UConn Health's Dr. Pramod Srivastava has opened a clinical trial for a personalized vaccine against ovarian cancer that he hopes proves its safety and effectiveness, sets the stage for commercial development and lays the groundwork for treating other cancers.